Noah Greenspan, DPT, discusses how oxygen therapy, detailed evaluation, and trial-and-error approaches may help manage long ...

CMMI’s agenda centers on productivity and value-based payment expansion, including outcomes-based reimbursement, Most-Favored ...

A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...

GPT-4o achieved ICC/CCC of 0.815/0.866 versus in-person SALT scoring and 0.833/0.817 versus image-based scoring, while expert ...

Beyond progression-free survival, the combination of teclistamab and daratumumab hyaluronidase-fihj showed deep clinical responses, notes Ajay K. Nooka, MD, MPH. Clinical data showed that 83% of ...

Persistent underperformance of prior oncology VBC models reflects failure to measurably improve outcomes while lowering total cost, sustaining skepticism despite ongoing urgency to redesign care ...

Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...

NSFG 2015–2019 analyses excluded surgical sterility and clinical infertility, yet >20% reported diagnosed reproductive health conditions, highlighting a sizable s ...

Analyses of a 40% SHI sample estimated vitiligo prevalence at 0.19% in 2020 (~148,000 individuals nationally), enabling population-level quantification of psychiatric comorbidity patterns. Depressive ...

Orphan status in the U.S. can confer clinical-trial tax credits, user-fee exemptions, and up to seven years of post-approval market exclusivity for rare-disease programs. As a deuterated form of ...

With the launch of such a service, questions surrounding what it is exactly and its efficacy in reducing drug prices have been a prominent discussion. Below, we answer some frequently asked questions ...

Rising national health expenditures and high administrative overhead create a compelling but not definitive business case for AI-enabled automation across billing, claims, and compliance functions.